Acupuncture Alleviates Levodopa-Induced Dyskinesia via Melanin-Concentrating Hormone in Pitx3-Deficient aphakia and 6-Hydroxydopamine-Lesioned Mice

[1]  Songhee Jeon,et al.  Novel Neuroprotective Effects of Melanin-Concentrating Hormone in Parkinson’s Disease , 2017, Molecular Neurobiology.

[2]  J. Krauss,et al.  Altered somatosensory cortex neuronal activity in a rat model of Parkinson's disease and levodopa-induced dyskinesias , 2017, Experimental Neurology.

[3]  J. Bittencourt,et al.  The Melanin-Concentrating Hormone as an Integrative Peptide Driving Motivated Behaviors , 2017, Front. Syst. Neurosci..

[4]  Shengjie Dong,et al.  An updated meta-analysis of amantadine for treating dyskinesia in Parkinson's disease , 2017, Oncotarget.

[5]  Songhee Jeon,et al.  Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson’s disease , 2017, BMC Complementary and Alternative Medicine.

[6]  M. Coriolano,et al.  Acupuncture as Adjuvant Therapy for Sleep Disorders in Parkinson's Disease. , 2017, Journal of acupuncture and meridian studies.

[7]  Y. Asmann,et al.  Lipocalin-2 protects the brain during inflammatory conditions , 2017, Molecular Psychiatry.

[8]  D. Brooks,et al.  Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease , 2016, Neurology.

[9]  M. Jahanshahi,et al.  Neural substrates and potential treatments for levodopa-induced dyskinesias in Parkinson’s disease , 2016, Reviews in the neurosciences.

[10]  Myungwon Jin,et al.  Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System , 2016, The Journal of Neuroscience.

[11]  J. Jankovic,et al.  Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia , 2016, Drugs.

[12]  M. Heilig,et al.  Erratum to: The melanin-concentrating hormone-1 receptor modulates alcohol-induced reward and DARPP-32 phosphorylation , 2016, Psychopharmacology.

[13]  Manoj A Upadhya,et al.  CART modulates the effects of levodopa in rat model of Parkinson’s disease , 2016, Behavioural Brain Research.

[14]  R. Barker,et al.  Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease , 2016, Movement disorders : official journal of the Movement Disorder Society.

[15]  A. Lang,et al.  Clozapine in Parkinsonian Rest Tremor: A Review of Outcomes, Adverse Reactions, and Possible Mechanisms of Action , 2016, Movement disorders clinical practice.

[16]  T. Vanderah,et al.  The pharmacology of neurokinin receptors in addiction: prospects for therapy , 2015, Substance abuse and rehabilitation.

[17]  Gilberto Fisone,et al.  Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease , 2015, Progress in Neurobiology.

[18]  F. Wang,et al.  Effect and Potential Mechanism of Electroacupuncture Add-On Treatment in Patients with Parkinson's Disease , 2015, Evidence-based complementary and alternative medicine : eCAM.

[19]  N. Sousa,et al.  From the periphery to the brain: Lipocalin-2, a friend or foe? , 2015, Progress in Neurobiology.

[20]  Shinn-Jang Hwang,et al.  A clinical study of integrating acupuncture and Western medicine in treating patients with Parkinson's disease. , 2015, The American journal of Chinese medicine.

[21]  S. Hitchcock,et al.  Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia , 2015, Neurobiology of Disease.

[22]  Antonio Cerasa,et al.  A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias. , 2015, Brain : a journal of neurology.

[23]  R. Moratalla,et al.  Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3−/− aphakia mice , 2015, Neurobiology of Disease.

[24]  Hong Zhang,et al.  An Updated Meta-Analysis of the Efficacy and Safety of Acupuncture Treatment for Cerebral Infarction , 2014, PloS one.

[25]  Harald Binder,et al.  Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries. , 2014, Parkinsonism & related disorders.

[26]  E. Nattie,et al.  The Role of Melanin Concentrating Hormone (MCH) in the Central Chemoreflex: A Knockdown Study by siRNA in the Lateral Hypothalamus in Rats , 2014, PloS one.

[27]  G. Conductier,et al.  The melanin-concentrating hormone receptors: neuronal and non-neuronal functions. , 2014, International journal of obesity supplements.

[28]  Emiri T. Mandeville,et al.  Neuronal Production of Lipocalin-2 as a Help-Me Signal for Glial Activation , 2014, Stroke.

[29]  W. Maixner,et al.  From peripheral to central: the role of ERK signaling pathway in acupuncture analgesia. , 2014, The journal of pain : official journal of the American Pain Society.

[30]  E. Bézard,et al.  Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia , 2014, Neurobiology of Disease.

[31]  I. Shim,et al.  Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of l-dopa by normalizing Parkinson's disease-induced neurochemical imbalance , 2014, Brain Research.

[32]  Wei Dong,et al.  Subchronic exposure to lead acetate inhibits spermatogenesis and downregulates the expression of Ddx3y in testis of mice. , 2013, Reproductive toxicology.

[33]  D. Dexter,et al.  Parkinson disease: from pathology to molecular disease mechanisms. , 2013, Free radical biology & medicine.

[34]  Pablo Torterolo,et al.  Melanin-concentrating hormone control of sleep-wake behavior. , 2013, Sleep medicine reviews.

[35]  M. Lauková,et al.  Intranasal infusion of melanocortin receptor four (MC4R) antagonist to rats ameliorates development of depression and anxiety related symptoms induced by single prolonged stress , 2013, Behavioural Brain Research.

[36]  Bin Xu,et al.  Electroacupuncture regulates glucose-inhibited neurons in treatment of simple obesity , 2013, Neural regeneration research.

[37]  C. Wallraven,et al.  Inserting needles into the body: a meta-analysis of brain activity associated with acupuncture needle stimulation. , 2013, Journal of Pain.

[38]  J. Kim,et al.  Electroacupuncture Acutely Improves Cerebral Blood Flow and Attenuates Moderate Ischemic Injury via an Endothelial Mechanism in Mice , 2013, PloS one.

[39]  P. Reddy,et al.  Neurotransmitter CART as a New Therapeutic Candidate for Parkinson’s Disease , 2013, Pharmaceuticals.

[40]  J. Nagel,et al.  Increased Susceptibility of Melanin-Concentrating Hormone-Deficient Mice to Infection with Salmonella enterica Serovar Typhimurium , 2012, Infection and Immunity.

[41]  J. Nagel,et al.  Reduced Intestinal Tumorigenesis in APCmin Mice Lacking Melanin-Concentrating Hormone , 2012, PloS one.

[42]  A. Lessard,et al.  Apomorphine-evoked redistribution of neurokinin-3 receptors in dopaminergic dendrites and neuronal nuclei of the rat ventral tegmental area , 2012, Neuroscience.

[43]  P. Reddy,et al.  CART Peptide Is a Potential Endogenous Antioxidant and Preferentially Localized in Mitochondria , 2012, PloS one.

[44]  I. Shim,et al.  Acupuncture Enhances the Synaptic Dopamine Availability to Improve Motor Function in a Mouse Model of Parkinson's Disease , 2011, PloS one.

[45]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[46]  Hackjin Kim,et al.  Parsing brain activity associated with acupuncture treatment in Parkinson's diseases , 2009, Movement disorders : official journal of the Movement Disorder Society.

[47]  P. Greengard,et al.  Inhibition of mTOR Signaling in Parkinson’s Disease Prevents l-DOPA–Induced Dyskinesia , 2009, Science Signaling.

[48]  J. Belluzzi,et al.  The melanin-concentrating hormone system modulates cocaine reward , 2009, Proceedings of the National Academy of Sciences.

[49]  Younbyoung Chae,et al.  The neural substrates of verum acupuncture compared to non-penetrating placebo needle: An fMRI study , 2009, Neuroscience Letters.

[50]  P. Jenner.  Molecular mechanisms of L-DOPA-induced dyskinesia , 2008, Nature Reviews Neuroscience.

[51]  Douglas R. Porter,et al.  Dysregulation of the Mesolimbic Dopamine System and Reward in MCH−/− Mice , 2008, Biological Psychiatry.

[52]  C. Pothoulakis,et al.  Melanin-concentrating hormone as a mediator of intestinal inflammation , 2008, Proceedings of the National Academy of Sciences.

[53]  K. Chergui,et al.  Neurokinin B/NK3 receptors exert feedback inhibition on l-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease , 2008, Neuropharmacology.

[54]  X. Weng,et al.  Activation of the hypothalamus characterizes the response to acupuncture stimulation in heroin addicts , 2007, Neuroscience Letters.

[55]  Kwang-Soo Kim,et al.  Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson’s disease , 2007, Neurobiology of Disease.

[56]  A. Vicentic,et al.  The CART (Cocaine- and Amphetamine-Regulated Transcript) System in Appetite and Drug Addiction , 2007, Journal of Pharmacology and Experimental Therapeutics.

[57]  J. Langston,et al.  The parkinson's complex: Parkinsonism is just the tip of the iceberg , 2006, Annals of neurology.

[58]  H. Lindgren,et al.  A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function , 2004, Neurobiology of Disease.

[59]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[60]  J Duhault,et al.  Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague–Dawley rats , 2002, International Journal of Obesity.

[61]  B. Min,et al.  Modulation of natural killer cell activity affected by electroacupuncture through lateral hypothalamic area in rats , 2002, Neuroscience Letters.

[62]  Jen-Chuen Hsieh,et al.  Activation of the hypothalamus characterizes the acupuncture stimulation at the analgesic point in human: a positron emission tomography study , 2001, Neuroscience Letters.

[63]  I. Izquierdo,et al.  Melanin-concentrating hormone (MCH) modifies memory retention in rats ☆ , 1999, Peptides.

[64]  Masao Kobori,et al.  The acupuncture point and its connecting central pathway for producing acupuncture analgesia , 1993, Brain Research Bulletin.

[65]  P. Overton,et al.  Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat. , 1992, European journal of pharmacology.

[66]  M. Heilig,et al.  The melanin-concentrating hormone-1 receptor modulates alcohol-induced reward and DARPP-32 phosphorylation , 2016, Psychopharmacology.

[67]  T. Mizushima.  Treatment Results between Matched Pair of L-dopa Medication Treatment and Acupuncture Treatment Combination on Parkinson Disease-The Randomized Controlled Trial between 2 Groups- , 2011 .